Hypertension Disease Summary

Last updated: 10 June 2026

Overview

Hypertension is the medical term for high blood pressure (BP) as stated in the Introduction section. This may be due to multiple factors which are discussed in the Pathophysiology section.

An estimated 1.28 billion adults aged 30-79 years old have hypertension according to the World Health Organization (WHO) and two-thirds of these are living in low- and middle-income countries. The incidence of hypertension locally and regionally is featured in the Epidemiology section.

Various consensus guidelines are available as standard references for the definition of hypertension.  The differences in the classification of BP are shown in the Classification section.  The stages of hypertension are also in this section.


Hypertension_Disease SummaryHypertension_Disease Summary

History and Physical Examination

A good history and physical examination should be taken during the primary visit of the patient. Signs and symptoms and factors to look for in these examinations are enumerated and discussed in the History and Physical Examination sections.

Proper BP measurements in and out of the clinic are essential in screening patients suspected of having hypertension. These are discussed in the Screening section as well as the BP levels defining hypertension in different settings. Discussion on screening for secondary causes of hypertension or evidence of target organ damage is also in this section.  

Diagnosis

Laboratory Tests and Ancillaries and Imaging studies to be considered in the work-up of patients with hypertension are discussed in these sections.

Causes of secondary hypertension should be ruled out, especially in patients at extremes of age, and these are enumerated in the Differential Diagnosis section.

Management

Patients with hypertension should be assessed further to identify secondary causes, target organ damage, cardiovascular disease risk (CVD) factors or other disorders that may affect prognosis.  This is discussed in the Evaluation section. Risk stratification for guidance on the management of hypertension and subsequent follow-up is also featured in this section.

Treatment goals, target BP, treatment initiation and regimen, and choice of antihypertensive agents are discussed in detail in the Principles of Therapy section.

The WHO recommends the use of medications from any of the following three drug classes as first-line antihypertensive agents: Angiotensin-converting enzyme (ACE) inhibitors or angiotensin receptor blockers (ARBs), calcium antagonists, and thiazide and thiazide-like diuretics. These are discussed in detail in the Pharmacological Therapy section. Other antihypertensive agents, antihypertensive combinations and management of resistant hypertension discussions are also in this section.

Several non-drug options to consider that may aid in the management of hypertension such as patient education (eg BP measurement and monitoring) and lifestyle modification (eg weight reduction and maintenance, dietary changes, regular exercise, limiting alcohol consumption, smoking cessation) are featured in the Nonpharmacological section.  

It is recommended to have regular assessment of BP control to determine the effectiveness of the management given and to identify any hypertension-mediated organ damage. This is discussed in the Monitoring section. 

Frequently Asked Questions

How is blood pressure classified in adults?
Blood pressure classification is based on the average of at least two properly measured seated readings obtained during at least two office visits. The 2025 AHA/ACC classification defines stage 1 hypertension as 130–139 mmHg systolic or 80–89 mmHg diastolic and stage 2 hypertension as at least 140/90 mmHg. The 2024 ESC classification defines hypertension as at least 140/90 mmHg. Read more
How should hypertension be confirmed after screening?
Hypertension is generally confirmed by repeating blood pressure measurement within one to four weeks or by averaging readings obtained on at least two separate occasions. The reassessment interval should be shorter when blood pressure is substantially elevated or cardiovascular disease or target organ damage is present. Ambulatory or home blood pressure monitoring is recommended to confirm the diagnosis and identify masked or white-coat hypertension. Read more
Which drugs are first-line for hypertension?
Recommended first-line antihypertensive classes are angiotensin-converting enzyme inhibitors or angiotensin receptor blockers, calcium antagonists, and thiazide or thiazide-like diuretics. Drug selection should consider age, comorbidities, previous treatment response, adverse effects, possible drug interactions, pregnancy potential, affordability and availability. ACE inhibitors or angiotensin receptor blockers are particularly appropriate when hypertension coexists with chronic kidney disease. Read more
Which lifestyle measures support blood pressure control?
Lifestyle modification is central to hypertension prevention and treatment. Recommended measures include weight reduction in patients who are overweight or obese, reduced salt intake, a Mediterranean or DASH-style diet, regular aerobic and resistance exercise, moderation or avoidance of alcohol and smoking cessation. Dietary potassium is preferably obtained from food but requires caution in chronic kidney disease or during treatment with medicines that reduce potassium excretion. Read more
How often should hypertension follow-up be scheduled?
Clinic visits should generally occur monthly or more frequently during the first three months after treatment initiation. Once blood pressure is controlled and stable, annual follow-up may be appropriate. Patients with high cardiovascular risk, difficult blood pressure control or pre-existing hypertension-mediated organ damage require closer monitoring. Follow-up should assess adherence, adverse effects, lifestyle measures, physical findings, blood pressure control and the need for laboratory testing. Read more